These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis. Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247 [TBL] [Abstract][Full Text] [Related]
52. [Cardioprotection: an essential component for predialysis chronic renal failure treatment]. Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513 [TBL] [Abstract][Full Text] [Related]
53. Vascular calcification and arterial stiffness in chronic kidney disease: implications and management. Toussaint ND; Kerr PG Nephrology (Carlton); 2007 Oct; 12(5):500-9. PubMed ID: 17803475 [TBL] [Abstract][Full Text] [Related]
54. [Arterial stiffness--pathophysiological significance and practical aspects of assessment]. Stróźecki P; Kozłowski M; Kurowski R; Naruszewicz R Przegl Lek; 2005; 62 Suppl 2():11-4. PubMed ID: 16623110 [TBL] [Abstract][Full Text] [Related]
55. Effect of ramipril on left ventricular mass in normotensive hemodialysis patients. Yu WC; Lin YP; Lin IF; Chuang SY; Chen CH Am J Kidney Dis; 2006 Mar; 47(3):478-84. PubMed ID: 16490627 [TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of ankle-brachial index, brachial-ankle pulse wave velocity, flow-mediated dilation, and nitroglycerin-mediated dilation in end-stage renal disease. Morimoto S; Yurugi T; Aota Y; Sakuma T; Jo F; Nishikawa M; Iwasaka T; Maki K Am J Nephrol; 2009; 30(1):55-63. PubMed ID: 19204388 [TBL] [Abstract][Full Text] [Related]
57. Vascular disease and atherosclerosis in uremia. London GM Nefrologia; 2005; 25 Suppl 2():91-5. PubMed ID: 16050410 [TBL] [Abstract][Full Text] [Related]